15 mg/kg (maximum: 16 mg/dose) as a single dose (manufacturer's labeling)
Warnings
Ondansetron Tablets, USP are oval, standard convex, film-coated tablets and are available in the following strengths: • 4 mg - white tablet with ‘4’ on one side and
The recommended oral dose is 24 mg
Ondansetron is an anti-sickness medicine, also
Drug Images Highlights for ondansetron Ondansetron orally disintegrating tablet is available as a brand-name drug and as a generic drug
The 4 mg tablets are white film
ODT and film formulations should be used with dry hands and immediately placed on the tongue
The other ingredients are: poly (vinyl alcohol), Macrogol 1000, acesulfame Then administer 4 mg three times a day for 1 to 2 days after completion of chemotherapy
The breakline is only to facilitate breaking if necessary for ease of swallowing and not to divide into equal doses
Ondansetron has excellent utility as an antiemetic drug, and it is effective against nausea and vomiting of various etiologies
Headache, lightheadedness, dizziness, drowsiness, tiredness, or constipation may occur
Then, one 8-mg film is taken two times a day (every 12 hours) for 1 to 2 days
8 mg syrup or tablet every 12 hours
Water is not needed
Liquid (solution): 5 mg/m 2 or 8 mg IV plus 8 mg syrup or tablet after 12 hours
≤ 10kg
Film/ 4 mg and 8 mg ondansetron acesulfame potassium, glycerol anhydrous, levomenthol, polysorbate 80, poly (ethylene glycol) 1000, poly (vinyl alcohol), rice starch and titanium dioxide INDICATIONS AND CLINICAL USE Adults ONDISSOLVE® ODF (ondansetron) Orally Disintegrating Film is indicated for: Ondansetron tablets, USP for oral administration contain ondansetron hydrochloride USP (dihydrate) equivalent to 4 mg or 8 mg or 24 mg of ondansetron
Each film-coated tablet also contains the inactive ingredients anhydrous lactose, microcrystalline cellulose, pregelatinized starch, magnesium stearate, triacetin, titanium dioxide and
(1) Ondansetron tablets, USP for oral administration contain ondansetron hydrochloride USP (dihydrate) equivalent to 4 mg or 8 mg of ondansetron
Purpose: This study was conducted to compare the bioavailability of two 8 mg ondansetron oral soluble film formulations
They are supplied as follows: NDC 45963-539-30 Bottles of 30 Store at 20° to 25°C (68° to 77°F)